Skip to content
Medical Health Aged Care

Medical colleges unite to improve specialist access and affordability for all Australians

Council of Presidents of Medical Colleges 2 mins read

At a time when Australians are increasingly concerned about access to specialist care, including out-of-pocket costs and unexpected bills, Australia’s 16 specialist medical colleges have come together on a combined national framework on ethical billing and patient protection.

The Council of Presidents of Medical Colleges (CPMC) launched its national Professionalism Framework on ethical billing and fee transparency at Parliament House today. 

The Framework was launched by CPMC Chair Associate Professor Kerin Fielding and the Assistant Minister for Health and Aged Care, the Hon. Rebecca White MP.

The framework establishes shared expectations for ethical billing, fee transparency, and informed financial consent – reinforcing the medical profession’s commitment to patient-centred care. 

It sets out clear principles: plain-language disclosure of all costs; genuine informed financial consent as a prerequisite to treatment; and compassionate billing that accounts for patients' circumstances. It also establishes an explicit expectation that specialists consistently uphold these principles in their practice. 

“Patients deserve clear information about the cost of their care and the confidence that billing practices are fair, transparent and respectful,” said CPMC Chair Associate Professor Kerin Fielding.

“This framework reinforces that informed financial consent is not complete unless patients have had a genuine opportunity to understand the financial implications of their care, including available alternatives.”

The framework makes clear that patients are entitled to clear, upfront information about the cost of their care, while billing practices that exploit vulnerabilities, obscure costs, or include undisclosed fees are inconsistent with professional standards and should not form part of contemporary specialist practice.

While specialist medical colleges do not set or regulate fees, CPMC said the profession has a responsibility to uphold transparency in billing practices so that patients can make informed decisions about their care.

CPMC has committed to working with the Commonwealth to ensure the Medical Costs Finder website delivers better transparency for patients seeking specialist medical care.

The colleges will continue to work constructively with government, insurers and consumer representatives to improve access to specialist care and reduce financial barriers for patients, so that every Australian can access affordable, high-quality specialist care without risking financial hardship. 


Contact details:

CPMC Media: 0474 473 493

Email: [email protected]

Media

More from this category

  • Medical Health Aged Care, Science
  • 29/03/2026
  • 18:27
The Thoracic Society of Australia and New Zealand (TSANZ)

TSANZ Announces 2026 Board Composition

Key Facts: Professor Vanessa McDonald elected as President-Elect of TSANZ, to serve one year before beginning a two-year presidential term in March 2027 Four new Member-Elected Directors appointed: Associate Professors Katrina Tonga and Nicole Goh, and Doctors Paul Dawkins and Richard Kim Professor Shyamali Dharmage re-elected for two more years; Professor Andrew Chan becomes Australian Branch Board Director. Five Board members stepping down, including Professor Anne Holland (Past President), after serving four-year terms. Announcement coincides with the release of the TSANZ Strategic Plan 2026-2031, focusing on lung health priorities Perth, March 2026 - The Thoracic Society of Australia and New…

  • Contains:
  • Medical Health Aged Care
  • 29/03/2026
  • 06:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies…

  • Contains:
  • Medical Health Aged Care
  • 29/03/2026
  • 02:11
Galderma SA

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.